XML 16 R7.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Retained Earnings
Beginning balance (in shares) at Jan. 31, 2022   299,037,805      
Beginning balance at Jan. 31, 2022 $ 5,780,018 $ 299 $ 3,749,514 $ (17,902) $ 2,048,107
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   858,055      
Issuance of common stock upon exercise of stock options 5,243 $ 1 5,242    
Issuance of common stock upon release of restricted stock units (in shares)   1,906,359      
Issuance of common stock upon release of restricted stock units 0 $ 2 (2)    
Issuance of common stock for employee stock purchase plan (in shares)   373,259      
Issuance of common stock for employee stock purchase plan 34,604   34,604    
Repurchase of common stock (in shares)   (4,088,971)      
Repurchases of common stock (425,946) $ (4) (425,942)    
Stock-based compensation expense 467,329   467,329    
Other comprehensive income (loss) (30,259)     (30,259)  
Net income 159,408       159,408
Ending balance (in shares) at Jul. 31, 2022   298,086,507      
Ending balance at Jul. 31, 2022 5,990,397 $ 298 3,830,745 (48,161) 2,207,515
Beginning balance (in shares) at Apr. 30, 2022   298,824,233      
Beginning balance at Apr. 30, 2022 5,947,887 $ 299 3,831,060 (45,237) 2,161,765
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   314,537      
Issuance of common stock upon exercise of stock options 1,899   1,899    
Issuance of common stock upon release of restricted stock units (in shares)   1,439,199      
Issuance of common stock upon release of restricted stock units 0 $ 2 (2)    
Issuance of common stock for employee stock purchase plan (in shares)   373,259      
Issuance of common stock for employee stock purchase plan 34,604   34,604    
Repurchase of common stock (in shares)   (2,864,721)      
Repurchases of common stock (293,534) $ (3) (293,531)    
Stock-based compensation expense 256,715   256,715    
Other comprehensive income (loss) (2,924)     (2,924)  
Net income 45,750       45,750
Ending balance (in shares) at Jul. 31, 2022   298,086,507      
Ending balance at Jul. 31, 2022 5,990,397 $ 298 3,830,745 (48,161) 2,207,515
Beginning balance (in shares) at Jan. 31, 2023   293,822,850      
Beginning balance at Jan. 31, 2023 $ 6,206,607 $ 294 4,104,880 (50,385) 2,151,818
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) 1,044,922 1,044,922      
Issuance of common stock upon exercise of stock options $ 7,686 $ 1 7,685    
Issuance of common stock upon release of restricted stock units (in shares)   5,535,351      
Issuance of common stock upon release of restricted stock units 0 $ 6 (6)    
Issuance of common stock for employee stock purchase plan (in shares)   552,904      
Issuance of common stock for employee stock purchase plan 32,513 $ 1 32,512    
Stock-based compensation expense 544,450   544,450    
Other comprehensive income (loss) 13,678     13,678  
Net income 197,418       197,418
Ending balance (in shares) at Jul. 31, 2023   300,956,027      
Ending balance at Jul. 31, 2023 7,002,352 $ 302 4,689,521 (36,707) 2,349,236
Beginning balance (in shares) at Apr. 30, 2023   297,455,726      
Beginning balance at Apr. 30, 2023 6,524,107 $ 298 4,391,418 (34,871) 2,167,262
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   542,954      
Issuance of common stock upon exercise of stock options 3,417   3,417    
Issuance of common stock upon release of restricted stock units (in shares)   2,404,443      
Issuance of common stock upon release of restricted stock units 0 $ 3 (3)    
Issuance of common stock for employee stock purchase plan (in shares)   552,904      
Issuance of common stock for employee stock purchase plan 32,513 $ 1 32,512    
Stock-based compensation expense 262,177   262,177    
Other comprehensive income (loss) (1,836)     (1,836)  
Net income 181,974       181,974
Ending balance (in shares) at Jul. 31, 2023   300,956,027      
Ending balance at Jul. 31, 2023 $ 7,002,352 $ 302 $ 4,689,521 $ (36,707) $ 2,349,236